The AlphaLISA™ Human cIAP1 BIR2 Binding Kit is designed to screen and characterize compounds that specifically bind the E3 ligase, cIAP1 BIR2 domain, using Alpha Technology.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Protein-Protein Interaction |
Sample Volume | 5 µL |
The AlphaLISA™ Human cIAP1 BIR2 Binding Kit is designed to screen and characterize compounds that specifically bind the E3 ligase, cIAP1 BIR2 domain, using Alpha Technology.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
cIAP1, also called BIRC2, is a member of the Inhibitor of Apoptosis Proteins (IAP) family. IAP proteins are involved in multiple biological processes, such as innate immunity, and play an important role in apoptosis inhibition. cIAP1 overexpression has been associated with cancer resistance, making it an attractive target in cancer therapy where several therapeutic strategies have been investigated, such as SMAC mimetics.
AlphaLISA technology allows the detection of molecules of interest in a no-wash, highly sensitive, quantitative assay. In an AlphaLISA assay, a biotinylated anti-analyte antibody binds to the Streptavidin-coated Donor beads while another anti-analyte antibody is conjugated to AlphaLISA Acceptor beads. In the presence of the analyte, the beads come into close proximity. The excitation of the Donor beads causes the release of singlet oxygen molecules that triggers a cascade of energy transfer in the Acceptor beads, resulting in a sharp peak of light emission at 615 nm.
Application |
Protein-Protein Interaction
|
---|---|
Automation Compatible |
Yes
|
Brand |
AlphaLISA
|
Detection Modality |
Alpha
|
Product Group |
Kit
|
Sample Volume |
5 µL
|
Shipping Conditions |
Shipped in Blue Ice
|
Target |
clAP1 BIR2
|
Target Class |
Binding Assay
|
Technology |
Alpha
|
Therapeutic Area |
Autoimmunity
Neuroscience
Oncology
|
Unit Size |
500 Assay Points
|
Are you looking for resources, click on the resource type to explore further.
Proteolysis Targeting Chimaeras (PROTACs) are innovative small molecules that revolutionize drug discovery. They consist of two...
We are here to answer your questions.